2024-09-07 - Analysis Report
## Lilly (LLY) Stock Analysis

**Company Overview:** Eli Lilly and Company is a global pharmaceutical company that researches, develops, manufactures, and markets pharmaceutical products.

**Performance Analysis:**

**1. Performance vs. S&P 500 (VOO):**

* **LLY Cumulative Return:** 559.02%
* **VOO Cumulative Return:** 84.86%
* **Difference:** 474.16%
* **Relative Divergence:** 94.48% (indicating that LLY has outperformed VOO by a significant margin historically, currently sitting at the 94.48 percentile of its historical divergence range)

**2. Recent Price Action:**

* **Closing Price:** $946.31
* **5-day Moving Average:** $950.4
* **20-day Moving Average:** $923.73
* **60-day Moving Average:** $892.32

**3. Technical Indicators:**

* **RSI:** 57.49 (Neutral, neither overbought nor oversold)
* **PPO:** 0.08 (Positive, suggesting potential upside momentum)
* **Delta_Previous_Relative_Divergence:** 17.0 (Positive, indicating short-term bullish momentum)
* **Expected Return:** 26.62% (Potential 5-year return based on current investment amount)

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 3.29 | $11.30B |
| 2024-04-30 | 2.49 | $8.77B |
| 2023-11-02 | -0.06 | $9.50B |
| 2023-08-08 | 1.96 | $8.31B |
| 2024-08-08 | 1.96 | $8.31B |

* **Most recent earnings:**  The company beat analyst expectations with Q2 2024 EPS of $3.29, exceeding the estimated $2.94. Revenue also surpassed expectations, reaching $11.30B against an estimated $10.89B. 

**Overall Analysis:**

Lilly (LLY) has significantly outperformed the S&P 500 (VOO) over time, demonstrating strong historical performance.  Recent price action suggests a potential upward trend, supported by technical indicators like the PPO and Delta_Previous_Relative_Divergence.  The most recent earnings report confirms strong performance, exceeding expectations on both EPS and revenue. The high expected return further adds to the positive outlook for LLY. Overall, the stock shows strong performance, positive technical indicators, and a promising outlook based on recent earnings, suggesting potential for continued growth. 
